buy Cerebrolysin

CEREBROLYSIN® 1-20 ml Solution, 5-10 Ampoules

Clear
Quantity
2 - 3
4 - 6
7 - 8
9 +
Discount
5%
7%
9%
10%
Discounted price
-
-
-
-

Buy Cerebrolysin Online!

Cerebrolysin is a mix of enzymatically treated peptides derived from pig brains. Its constituents can include neuropeptides that are similar to fragments of natural neurotrophic factors (NTF) for example ciliary neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF), glial cells derived neurotrophic factor (GDNF), nerve growth factor (NGF), and insulin-like growth factor (IGF).

Cerebrolysin has been studied for potential use in a wide variety of neurodegenerative disorders. It can be beneficial in the treatment of dementia including Alzheimer’s disease, stroke, and traumatic brain injury (TBI). 

Cerebrolysin is available in different ampoule sizes: from 1ml to 20ml 📦 Fast US Domestic Delivery and International Shipping 📦


Generic name: Cerebrolysin, FPF-1070
Form: Solution for intramuscular and intravenous injections in ampoules/vials.
Form description: Transparent solution of amber color
Active ingredient: 215.2 mg of Cerebrolysin concentrate in an aqueous solution
Excipients: Sodium hydroxide and water for injection
СAS Number: 12656-61-0
ATC code: N06ВХ Nootropics
Shelf life: 5 years. Do not use it beyond the expiration date printed on the package.
Storage: Store at temperatures not exceeding 25°C (77°F). Do not freeze. Protect from light.
Manufacturer: EVER Pharma, Austria. www.everpharma.com

What is Cerebrolysin Used For?

Cerebrolysin is a neuropeptide preparation with neuroprotective and neurorestorative effects. It comes in an injection form. Cerebrolysin ampoules have several dosages for the convenience of use.

Cerebrolysin is based on low molecular weight biologically active neuropeptides (20%) and amino acids (80%) isolated from porcine brain tissue by enzymatic cleavage.

The “smart drug” is used in the complex treatment of cerebrovascular disorders:

  • Strokes and stroke complications;
  • Alzheimer’s disease and other types of dementia;
  • Traumatic brain injuries;
  • Spinal cord injuries;
  • ADHD in children;
  • Antidepressant-resistant depressions;
  • Other brain diseases.

What are Cerebrolysin Benefits?

Cerebrolysin is used in the complex treatment of acute and chronic disorders of the central nervous system (CNS). It supports endogenous repair and recovery processes after an injury or degenerative disease. It also helps to protect the brain against pathological events and cascades. Cerebrolysin mechanism of action resides in its ability to activate endogenous defense mechanisms (ESM), which include four main components: 1) Neurotrophic, 2) Neuroprotection, 3) Neuroplasticity, and 4) Neurogenesis.

As practice shows, repeated and long-term courses of treatment with Cerebrolysin peptide lead to an increase in the effectiveness of neuro-therapy, especially in relation to improved cognitive and behavioral functions.

In clinical practice, Cerebrolysin is known to reduce symptoms of depression, cognitive impairment, and autonomic disorders. It is said to relieve pain syndrome and enhance the effect of tricyclic antidepressants.

What are Cerebrolysin Side Effects?

Rare cases of adverse reactions to Cerebrolysin may include fatigue, headaches, dizziness, insomnia, etc.

Please note that it is important to follow the recommendations of the drug administration to minimize the chance of adverse reactions. Please refer to our dosage section for more information.

Is Cerebrolysin Safe to Take?

Cerebrolysin has an excellent safety record. Unless taken in large amounts (>10 ml), adverse reactions are mild and rare.

The drug may be even prescribed with caution in the first trimester of pregnancy and during lactation. The results of experimental studies suggest that Cerebrolysin is void of teratogenic or toxic effects on the fetus. Consultation and supervision by a medical professional is required!

Special attention shall be taken when stacking Cerebrolysin with antidepressants, including MAO inhibitors.

Where To Buy Cerebrolysin?

Authentic Cerebrolysin ampoules for injection are available at CosmicNootropic. We offer the most popular forms: Cerebrolysin 5ml and Cerebrolysin 10ml ampoules as well as other volumes depending on the purpose of use.

You do not need a prescription to obtain Cerebrolysin online. Buy it with fast delivery in the USA and internationally. CosmicNootropic offers bulk discounts 👍

Check out our blog post
🧠 Comprehensive Cerebrolysin Review with FAQ Section 🧠

 


Legal Disclaimer
This product has not been approved by the US FDA. All statements on this page are for informational purposes only and have not been evaluated by the US FDA.
This product is not intended to diagnose, treat, cure, or prevent any disease. See more

What is the Optimal Cerebrolysin Dosage?

Cerebrolysin has indication-specific dosing. The most common regime for improving brain function is IM injections of 5 ml daily. The course of treatment is 4 weeks unless otherwise prescribed by your attending physician.

Dose recommendations from the manufacturer:

Condition Dosage    When to start    Duration
Stroke 20 – 50 ml   / as soon as possible / 10 – 21 days
Vascular dementia 10 – 30 ml   / as soon as possible / 1 cycle: 5 days a week/ 4 weeks, 2-4 cycles per year
Alzheimer’s disease   10 – 30 ml   / as soon as possible / 1 cycle: 5 days a week/ 4 weeks, 2-4 cycles per year
TBI 20 – 50 ml   / as soon as possible / 7 – 30 days

How to Inject Cerebrolysin?

The main ways of administering the drug are intramuscular (IM) and intravenous (IV). The gluteal region is the best spot to inject IM. Relax your muscle and inject slowly. Here is a couple of tips on how to make injections. Please do follow the sterility instructions!

 

CEREBROLYSIN OFFICIAL INSTRUCTION

  1. Rutheret al (1994) Efficacy of the Peptidergic Nootropic Drug Cerebrolysin in Patients with Senile Dementia of the Alzheimer Type (SDAT) https://www.ncbi.nlm.nih.gov/pubmed/8159781
  2. L. Francis-Turner, V. Valouskova (1996) Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study https://www.ncbi.nlm.nih.gov/pubmed/8848264
  3. Schwab et al (1997) Morphofunctional effects of moderate forebrain ischemia combined with short-term hypoxia in rats – protective effects of Cerebrolysin https://www.ncbi.nlm.nih.gov/pubmed/9085071
  4. V. Valouskova and A. Gschanes (1999) Effects of NGF, b-FGF, and Cerebrolysin on Water Maze Performance and on Motor Activity of Rats: Short- and Long-Term Study https://www.ncbi.nlm.nih.gov/pubmed/10082636
  5. Masliah et al (1999) Cerebrolysin Ameliorates Performance Deficits, and Neuronal Damage in Apolipoprotein E-Deficient Mice https://www.ncbi.nlm.nih.gov/pubmed/9972690
  6. Bae et al (2000) A Double-Blind, Placebo-Controlled, Multicenter Study of Cerebrolysin for Alzheimer’s Disease https://www.ncbi.nlm.nih.gov/pubmed/11129744
  7. Ruther et al (2000) Sustained improvements in patients with dementia of Alzheimer’s type (DAT) 6 months after termination of Cerebrolysin therapy https://www.ncbi.nlm.nih.gov/pubmed/11005546
  8. Ruether et al (2001) A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer’s disease https://www.ncbi.nlm.nih.gov/pubmed/11552768
  9. Hartbauer et al (2001) Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons https://www.ncbi.nlm.nih.gov/pubmed/11475013
  10. Hartbauer et al (2001) Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons https://www.ncbi.nlm.nih.gov/pubmed/11459078
  11. Eder et al (2001) Increased density of glutamate receptor subunit 1 due to Cerebrolysin treatment: An immunohistochemical study on aged rats https://www.ncbi.nlm.nih.gov/pubmed/12197668
  12. Panisset et al (2002) Cerebrolysin in Alzheimer’s disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent https://www.ncbi.nlm.nih.gov/pubmed/12111446
  13. Rockenstein et al (2003) The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance https://www.ncbi.nlm.nih.gov/pubmed/14628195
  14. Ladurner et al (2004) Neuroprotective treatment with Cerebrolysin in patients with acute stroke: a randomised controlled trial https://www.ncbi.nlm.nih.gov/pubmed/15583955
  15. Alvarez et al (2006) A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer’s disease https://www.ncbi.nlm.nih.gov/pubmed/16420392
  16. Rockenstein et al (2006) Cerebrolysin Decreases Amyloid-b Production by Regulating Amyloid Protein Precursor Maturation in a Transgenic Model of Alzheimer’s Disease https://www.ncbi.nlm.nih.gov/pubmed/16511867
  17. Wei et al (2007) Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease https://www.ncbi.nlm.nih.gov/pubmed/17318304
  18. Ren et al (2007) Cerebrolysin enhances functional recovery following focal cerebral infarction in rats https://www.ncbi.nlm.nih.gov/pubmed/17473393
  19. Alvarez et al (2008) Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate–severe traumatic brain injury https://www.ncbi.nlm.nih.gov/pubmed/18273537
  20. Muresanu et al (2008) A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: Cognitive improvement correlates with qEEG acceleration https://www.ncbi.nlm.nih.gov/pubmed/18048059
  21. Alvarez et al (2009) Reduced TNF-a and increased IGF-I levels in the serum of Alzheimer’s disease patients treated with the neurotrophic agent Cerebrolysin https://www.ncbi.nlm.nih.gov/pubmed/19531281
  22. Sharma et al (2010) Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat https://www.ncbi.nlm.nih.gov/pubmed/20633118
  23. Guekht et al (2011) Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial https://www.ncbi.nlm.nih.gov/pubmed/20656516
  24. Alcantara-Gonzalez et al (2012) Combined Administration of Cerebrolysin and Donepezil Induces Plastic Changes in Prefrontal Cortex in Aged Mice https://www.ncbi.nlm.nih.gov/pubmed/22826038
  25. Heiss (2012) Cerebrolysin in Patients With Acute Ischemic Stroke in Asia Results of a Double-Blind, Placebo-Controlled Randomized Trial https://www.ncbi.nlm.nih.gov/pubmed/22282884
  26. Menon et al (2012) Cerebrolysin, a Mixture of Neurotrophic Factors Induces Marked Neuroprotection in Spinal Cord Injury Following Intoxication of Engineered Nanoparticles from Metals https://www.ncbi.nlm.nih.gov/pubmed/22229324
  27. Chen et al (2013) Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study https://www.ncbi.nlm.nih.gov/pubmed/23656173
  28. Amiri-Nikpour et al (2014) Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke https://www.ncbi.nlm.nih.gov/pubmed/25516711
  29. Muresanu et al (2015) Cerebrolysin and Recovery After Stroke (CARS) A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial https://www.ncbi.nlm.nih.gov/pubmed/26564102
  30. Ziganshina et al (2016) Cerebrolysin for acute ischaemic stroke https://www.ncbi.nlm.nih.gov/pubmed/27918088

Related products

MEMOPROVE ® (N-Pep-12)

$85.00$90.00

Memoprove® is the first scientifically developed mixture of neuropeptides (N-PEP-12) which is designed to improve cognitive performance. Some call it “Cerebrolysin pills”. Memoprove acts similarly to NTP – regulatory proteins of the nervous tissue that determine the division, differentiation, and survival of neurons. Fast US domestic shipping is available.

PIRACETAM

$8.00$10.00

It has been more than 40 years since Cornelia E. Giurgea - a Romanian chemist - synthesized a compound that was "capable of selectively influencing integrative mechanisms of the brain”. This chemical compound was Piracetam®, which later gave birth to a whole range of pharmaceuticals which we now call nootropics. Fast US domestic shipping is available.

LICOPID ® (GMDP)

$23.00$99.00

Licopid® (or Lycopid) is an immunomodulator containing a complete synthetic analogue of natural GMDP or glucosaminyl muramyl dipeptide. Once in the body, Lycopid mimics the natural process of detecting fragments of peptidoglycan bacteria. Thus, the effect of the drug is as close as possible to the process of natural immunoregulation.

CORTEXIN ®

$45.00$89.00

Cortexin® is a mixture of neuropeptide fractions, amino acids, vitamins and minerals. Cortexin was shown to provide a normalizing effect on many functions of the brain. It has been used in children and adults for a wide variety of indications including ADHD, TBI and minor cerebral problems. Fast US domestic shipping is available.